| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cellular Biology |
From the School of Medical Sciences and Bosch Institute (Y.-K.J., Y.C., D.L., O.L.G., D.G.A.), University of Sydney, and Victor Chang Cardiac Research Institute (H.C., R.M.G.), Australia; and the The Faculty of Medical and Health Sciences (M.B.C.), University of Auckland, New Zealand.
Correspondence to Yue-kun Ju, School of Medical Sciences (F13), University of Sydney, Sydney, NSW 2006, Australia. E-mail ju{at}physiol.usyd.edu.au
| Abstract |
|---|
|
|
|---|
Key Words: heart sinoatrial node TRPC store-operated Ca2+ channel
| Introduction |
|---|
|
|
|---|
In excitable cells, Ca2+ entry via voltage-sensitive Ca2+ channels and other pathways, such as Na+/Ca2+ exchange, can maintain store Ca2+ levels so that the possible role of SOCCs is less clear. Nevertheless, there is increasing evidence that SOCCs exist in various excitable cells, including cardiac ventricular muscle.4,5 In ventricular myocytes, PLC responses are generally modest with only small amounts of IP3 being produced.6 Thus release of Ca2+ through IP3R is probably too small to modify excitationcontraction coupling. However, atria myocytes express functional IP3R at 6 to 10 times higher levels than those in ventricules, and Ca2+ release from IP3R may be involved in the generation of arrhythmias.7 Furthermore, recent studies have shown that activation of PLC in the heart leads to Ca2+ release from perinuclear IP3R and thereby regulates nuclear-cytoplasmic cycling of transcription factors and alters gene expression.8 A similar role may be played by IP3 and the IP3R in skeletal muscle and SOCCs have been implicated in IGF-1 induced muscle hypertrophy.5,9
The identity of the genes that encode SOCCs remains uncertain. Studies of the transient receptor potential (TRP) gene from Drosophila showed that it encodes a PLC-activated Ca2+ permeable channel.10 Subsequently, 7 TRP channel homologues in mammals, termed TRPC1-TRPC7, have been identified and there is considerable evidence to indicate that TRPC1 can encode a SOCC.11 In addition, a recent study showed that overexpression of TRPC3 substantially enhanced SOCC activity in the heart.5
The importance of Ca2+ release from stores in cardiac pacemaking is now widely accepted.1214 In a previous study, we found that activation of the P2Y1 purinergic receptor by ATP results in modulation of pacemaker firing attirbutable to receptor-coupled PLC activation and depletion of SR Ca2+ stores.15 Because activation of SOCCs also involves PLC, we speculated that SOCCs might be present in pacemaker tissue.
In mammals, the sinoatrial node (SAN) is a heterogeneous tissue. The shape of the action potential and the rate of rise of the pacemaker potential change progressively from the periphery to the center, the latter being the leading pacemaker site.16 Expression of ionic channels, Ca2+ handling proteins, and gap junction proteins in the SAN also vary from center to periphery.17
In this study, we recorded intracellular Ca2+ signals from intact mouse SANs, a preparation in which the structural integrity and activity of the node is preserved. SOCC activity and expression of TRPC gene and proteins were examined in this preparation. These studies indicate that TRPCs might mediate SOCC activity and as a result, regulate pacemaker firing rate.
| Materials and Methods |
|---|
|
|
|---|
SAN Preparation
The right atrium was harvested from anesthetized (pentobarbital sodium 1 mg/kg, i.p.) male BalbC mice (7 to 10 weeks old) and opened under a dissecting microscope to expose the crista terminalis, the intercaval area, and the interatrial septum.16 A section of right atrial wall containing the SAN region was pinned to a thin Sylgard block and placed in a chamber on an inverted microscope stage. The epicardial surface of this SAN preparation was closest to the objective while the endocardial surface was continuously superfused with modified Tyrodes solution. All experiments were performed at 33°C.
Ca2+ Measurements
The SAN preparation was loaded with the membrane-permeant fluorescent Ca2+ indicator, indo-1-AM (10 µmol/L), in Tyrode solution. Fluorescent signals were recorded from a restricted region of the SAN area (about 150x150 µm) by using a rectangular diaphragm (Figure 1A). The analog signals were digitized and the expression (R-Rmin)/(Rmax-R) calculated, which is linearly related to [Ca2+]i (for details see Kao18). In some experiments, confocal microscopy was used to collect data from the SAN preparations that were loaded with fluo-4AM (10 µmol/L).
|
mRNA for TRPC Expression
Total RNA was isolated from 20 SANs using a RNAqueous 4PCR isolation kit (Ambion). Specific primers for mTRPC1, mTRPC2, mTRPC3, mTRPC4, mTRPC5, mTRPC6, and mTRPC7 were used for PCR amplification, respectively.19 To control for potential genomic DNA contamination, a cDNA reaction was performed but in the absence of reverse transcriptase and used as template for PCR reactions.
Immunohistochemistry
Rabbit polyclonal antibodies to TRPC1, TRPC3, TRPC4, and TRPC6 (1:50, 1:100, 1:50, and 1:200 dilution, respectively; Alomone Labs) were used to label the various TRPC isoforms in the SAN whole mount preparations and single pacemaker cells. Antibodies for hyperpolarization-activated, cyclic nucleotide-gate cation channels HCN4 (1:100; Alomone Labs), and connexin-43 (3 µg/mL; Chemicon) were also used to identify pacemaker region within the SAN.
Statistics
Data are expressed as mean±SEM, with the number of preparations as n. Statistical test were either Student paired or unpaired t test, and P<0.05 was taken as the level of significance.
| Results |
|---|
|
|
|---|
It is well established that ß-adrenergic stimulation increases heart rate via its effect on the pacemaker cells. Therefore, the effects of isoproterenol on pacemaker action potential and Ca2+ transient were examined. We found that in the presence of isoproterenol, firing rate increased by 38±7% (n=7, P<0.0001), and the amplitude of Ca2+ transients was increased by 69±21% (P<0.01, Figure 1D and 1E). The observations suggest that the Ca2+ signals were principally from the pacemaker cells rather than from other cell types in the SAN such as endothelial cells or fibroblasts.20
To confirm this notion, confocal images of the SAN were recorded in the presence of lidocaine (100 µmol/L) to leave only the central SAN cells firing.21 Figure 2A, a & b, shows consecutive images recorded from the central SAN, and Figure 2Ac shows a ratio image, demonstrating cyclic [Ca2+]i changes in the central region of the SAN but not surrounding regions. A line scan image across the SAN (Figure 2B) and the time course of [Ca2+]i changes (Figure 2C) show that it is possible to record and characterize spontaneous Ca2+ signals arising from the central regions of the SAN.
|
Store-Operated Ca2+ Influx in Pacemaker Cells
To study Ca2+ influx through SOCCs in the SAN, preparations were first incubated in Ca2+-free solution resulting in a substantial decline in resting [Ca2+]i and cessation of pacemaker activity (Figure 3A). Reintroduction of Ca2+ to the perfusate caused a small rise in [Ca2+]i and a recovery of pacemaker activity (Figure 3B). When SR Ca2+ uptake was inhibited with cyclopriazonic acid (CPA, 10 µmol/L), the resting [Ca2+]i increased significantly (Figure 3C). To further empty SR Ca2+ stores, SANs were incubated in Ca2+-free solution containing CPA for 15 minutes. Reintroduction of Ca2+ to the perfusate in the presence of CPA evoked a marked increase in [Ca2+]i (Figure 3D), a characteristic of SOCC activity, as observed in other tissues.22 Ca2+ influx in response to reintroduction of Ca2+ was 7.1±3.2-fold greater in the presence (Figure 3D) than in the absence of CPA (Figure 3B; P<0.03, n=11), a finding consistent with Ca2+ influx being activated in response to SR store depletion. Although it is not feasible to measure the SR store content in this multicellular preparation, the large rise in resting [Ca2+]i in the presence of CPA suggested that SR Ca2+ uptake was effectively blocked and, thus, that SR store content was substantially depleted (Figure 3C).
|
To examine the possibility that the Ca2+ influx was mediated by L-type Ca2+ channels or Na+/Ca2+ exchanger, we tested the effect of nifedipine or the Na+/Ca2+ exchanger inhibitor, KBR-7943. As shown in Figure 4A, 20µmol/L nifedipine had no effect on SOCC activity. In the presence of 5 µmol/L KBR-7943, Ca2+ influx was inhibited by 25±8% of the control (n=6) (Figure 4B). Therefore, even when L-type Ca2+ channels or Na+/Ca2+ exchange are inhibited, store depletion evokes an influx of Ca2+as would be expected from the presence of SOCCs.
|
To further confirm that this Ca2+ influx was mediated by SOCCs, we applied gadolinium (Gd3+), a known SOCC inhibitor. We found that 100 µmol/L Gd3+ reduced the maximum [Ca2+]i response by 73±8% (P<0.01, n=4; Figure 4C). It has been reported that SOCCs are also sensitive to SKF-96365 in several cell types.22 We found that 10 µmol/L SKF-96365 inhibited 65±9% of Ca2+ influx (P<0.001, n=8; Figure 4D). A summary of these pharmacological evaluations of SOCC activity in SAN is shown in Figure 4E.
Functional Role of SOCCs in the Mouse SAN
Previous studies have demonstrated that in toad and rabbit pacemaker cells, pacemaker activity is modulated by SR Ca2+ release.13,14 To test whether spontaneous pacemaker activity of mouse SAN is also sensitive to SR Ca2+ release, the SR Ca2+ release antagonist, ryanodine (20 µmol/L) was applied and found to reduced firing rate to 55±11% of control (n=6, P<0.03; Figure 5A, left).
|
SR Ca2+ release can also be affected by reducing SR Ca2+ content. Low concentrations of caffeine reduce SR Ca2+ content23 and were found to reduce the both Ca2+ transient and firing rate to 87±4% and 75±3% of control respectively (n=4, P<0.01; Figure 2D and 2E). SR Ca2+ content can also be reduced by inhibition of SR Ca2+ uptake with CPA,24 which has been reported to slow spontaneous activity in single pacemaker cells.25 We found that CPA had a marginal effect on pacemaker firing rate, reducing it to 81±9% control. Both ryanodine and CPA reduced the amplitude of Ca2+ transients to 21±5% (n=6, P<0.0004) and 48±4.5% of control (n=7, P<0.0003), respectively. In addition, CPA increased resting [Ca2+]i to 167±37% of control (P<0.0006), whereas ryanodine did not alter resting [Ca2+]i significantly. These effects of SR store modulators on the pacemaker firing rate were confirmed by using intracellular recording of action potentials on intact SANs, which revealed qualitatively similar effects (Figure 5B).
These results suggest that several mechanisms contribute to the role of SR loading in cardiac pacemaking. For instance, whereas depletion of SR stores by CPA and low dose caffeine may activate membrane channels, such as SOCCs, to generate an inward Ca2+ current, this would be offset by a decrease of inward Na+/Ca2+ exchanger current that was caused by reduced SR Ca2+ release. Because high concentrations of ryanodine (>10 µmol/L) do not affect store content,26 the reduction the firing rate seen when ryanodine was applied can be explained by its effects on Ca2+ release and the Na+/Ca2+ exchanger current without a direct effect mediated by SOCCs.
To explore the potential implications of SAN SOCC activity for pacemaker function, we examined the effect of SKF-96365 on spontaneous action potential firing rate (Figure 5B). SKF-96365 (10 µmol/L), which blocked SOCCs (Figure 4), slowed firing rate to 64±7% of control (P<0.005, n=5). Moreover, a further reduction in pacemaker firing to 27±4% (P<0.002, n=5) was observed when the SKF-96365 was administered together with the SR Ca2+ uptake blocker CPA (Figure 5B and 5C). With this combined treatment, resting [Ca2+]i fell to a level not different from to the control (Figure 5C and 5D). It should be noted that although this combined treatment reduced both the firing rate and Ca2+ transients, effects that were fully reversible, the upstroke of action potentials was unchanged (Figure 5C). Thus it seems likely that the effects of SKF on the pacemaker firing were not attributable to blockade of the L-type Ca2+ channels.27 A comparison of changes in resting and transient [Ca2+]i is shown in Figure 5D.
Expression of TRPC Gene and Proteins in SAN
It has been suggested that SOCCs are encoded by the TRPC gene family.28 We used RT-PCR to examine mRNA expression of the 7 known mammalian TRPC isoforms in SAN preparations. PCR products were generated using primers specific for TRPC1-TRPC7 isoforms; primers that were initially validated using mouse brain RNA, a tissue known to express all TRPC isoforms. TRPC1, 2, 3, 4, 6, and 7, but not TRPC5, transcripts were detected in SAN (Figure 6Aa). Using HCN4 as a positive control, we showed both mRNA (Figure 6Ab, supplemental Figure I) and protein expression (Figure 6Ba 6Bb) of HCN4 are higher in SAN than right atria.29 HCN4 immunoreactivity was observed in the SAN region but not in the CT and surrounding atrial tissue (Figure 6Ba and 6Bb). In contrast, Cx43 (Figure 6Bc and 6Bd) is absent from the central area of the SAN but is abundant in atria and peripheral SAN as also observed by others.16 These distinctive protein expression patterns enabled us to identify the central and peripheral SAN.
|
Polyclonal antibodies raised against human TRPC1, TRPC3, TRPC4, and TRPC6 were used to evaluate the expression of these proteins. We confirmed that there antibodies could detect the TRPC isoforms by Western blot analyses of mouse atrial lysates (supplemental Figure II).
When applied to SAN whole mount preparations, immunofluorescence was evident in both the central and peripheral SAN with antibodies against TRPC1, 3, 4, and 6. To further define the cell type expressing TRPCs in the central and peripheral SAN, single pacemaker cells were isolated and labeled with TRPC antibodies. The central or peripheral pacemaker cells were identified by their morphological appearance.17 Single pacemaker cells isolated from central (Figure 7a) and peripheral (Figure 7b) SAN all showed positive labeling with the TRPC antibodies. As observed in other cell types,3032 labeling was predominantly cytoplasmic with the TRPC1 antibody (Figure 7A). The TRPC3 antibody produced the most intense labeling, particularly in central pacemaker cells (Figure 7Ba), and membrane staining was evident in a peripheral pacemaker cell (Figure 7Bb). The TRPC4 antibody exhibited regions of intense labeling near the ends of cells, which may indicate colocalization of TRPC4 with gap junctions33 (Figure 7Ca and 7Cb). TRPC6 labeling of central pacemaker cell was very weak (Figure 7Da), and in the peripheral pacemaker cells sarcomeric banding patterns were often apparent (Figure 7Db). Negative controls (Figure 7c), in which the antibodies were preincubated with their relevant peptide antigen, confirmed the specificity of TRPC isoform labeling.
|
| Discussion |
|---|
|
|
|---|
The small size of the SAN in mouse, which makes single cell isolation more difficult, is an advantage for imaging studies. As the SAN is only
50 µm thick and is transparent, its dimensions are compatible with microscopic fields of view. In the present study we were readily able to record changes in [Ca2+]i in intact SANs. The SAN and surrounding regions were identified by their anatomical landmarks and typical pacemaker action potentials (Figure 1). In addition, we demonstrated the expected sensitivity of spontaneous SAN activity to ß-adrenergic stimulation. The use of a Na+ channel blocker, which inactivates peripheral SAN activity but leaves firing from the central area intact, further confirmed the distinction between peripheral and central SAN.36 Moreover, the SAN preparation used in this study is relatively easy to obtain, and the pacemaker function persists for many hours. Thus it offers considerable potential for the study of mouse models including those display abnormal pacemaker function.
Intracellular Ca2+ Stores and Store-Operated Ca2+ Entry in Pacemaker Cells
Although there is growing evidence that diastolic depolarization can be generated by an inward Na+/Ca2+ exchange current that is related to Ca2+-induced Ca+ release from the SR,37 it remains debatable whether SR Ca2+ release is essential for cardiac pacemaker function.38 In the present study, we found that ryanodine, CPA, and low concentrations of caffeine all slowed pacemaker firing rate, supporting a role for SR Ca2+ release in pacemaker function (Figures 2E, 5A, and 5
B).
Substantial Ca2+ influx could be induced by SR store depletion, which is a characteristic of SOCC activity (compare Figure 3B and 3D). The increase in [Ca2+]i induced by store depletion was not simply attributable to reduced Ca2+ buffering, because it was inhibited by 2 SOCC inhibitors, Gd3+ and SKF-96365 (Figure 4C and 4D). We also excluded the possibility that Ca2+ influx was attributable to L-type Ca2+ channels or reverse mode Na+/Ca2+ exchanger activity, given that Ca2+ entry was still evident after blockade of Ca2+ channels with nifedipine or inhibition of the exchanger with KBR-7943 (Figure 4A and 4B). Although the specificity of Gd3+ and SKF-96365 remains questionable, similar effects were achieved with both SOCC blockers. This supports the notion that store depletion promotes Ca2+ influx mediated via SOCC. In addition, the fact that blocking L-type Ca2+ channels had no effect on SOCC activity in SAN strengthens our conclusion that Gd3+ and SKF96365 were acting mainly through their effect on SOCCs.
TRPC Expression in the SAN
Having characterized the SAN preparation and provided evidence for the involvement of SOCC activity in pacemaker cell function, we investigated whether SOCC activity could be attributable to TRPCs and, if so, which isoform is involved. We found transcripts for all TRPC isoforms, except TRPC5, in the SAN; absence of TRPC5 expression in the heart has been noted in an earlier report.19
A recent study of adult ventricular myocytes overexpressing TRPC3 showed abundant SOCC activity that was inhibited with SKF-96365.5 We found that TRPC3 expression was particularly prominent in central pacemaker cells and that activity in SAN was also sensitive to SKF-96365, suggesting that TRPC3 might contribute to SOCC activity in mouse pacemaker cells. A quantitative measure of mRNA abundance of TRPC3 in various mouse tissues is shown in the online data supplement (supplemental Figure II). There was no significant difference in TRPC3 expression from different regions of the mouse heart. The predominantly cytoplasmic localization of all the TRPC channels is surprising given that the functional channel should be in the membrane. However, this is not an unusual observation as it has been observed in many cell types3032 and with 3 different antibodies to TRPC1.31 Given that TRPC3 has recently been shown to undergo constitutive cyclical trafficking between the plasma membrane and intracellular sites,39 it is possible that the failure to identify TRPCs membrane localization may be due to a short membrane retention time.
Possible Physiological Role of SOCC in SAN
Ca2+ entry is critical for the cell function, and SOCCs have been suggested to mediate Ca2+ entry in both excitable and nonexcitable cells.3 However, whether or not SOCCs contribute to cardiac pacemaking on a beat-to-beat basis remains unclear. We found that the SOCC blocker SKF-96563 slowed firing rate and, when SR Ca2+ stores were depleted with CPA, pacemaker firing was further slowed (Figure 5). These observations raise the possibility that the inward current through SOCCs can influence heart rate.
SOCCs have been proposed to provide a pacemaker current in other spontaneously firing cells such as neurons40 and interstitial cells of Cajal.41 In embryonic pacemaker cells, before functional pacemaker ionic channels have developed, IP3-dependent Ca2+ influx through SOCCs has been described and under these circumstances is thought to contribute to pacemaking.42 Although SOCCs may generate inward currents2 and thereby contribute to diastolic depolarization, store content may also affect Ca2+ handling, because release of Ca2+ is highly dependent on store Ca2+ content.43 In addition, the resting level of [Ca2+]i will also affect calcium extrusion via the Na+/Ca2+ exchanger, which can generate an inward current. Thus the exact timing of SR calcium release and its influence on pacemaker current(s) is likely to be directly related to SR content which will, in turn, reflect the balance between Ca2+ entry and extrusion. Our data suggest that SOCCs provide an additional important Ca2+ entry pathway to regulate SAN function.
An alternative or additional role for SOCC/TRPC in pacemaker cells is suggested by a recent study showing that TRPC1 also forms a stretch-activated cation channel.44 It has been long known that stretch of the atria increases heart rate,45 although the mechanism involved is unknown.46 If TRPC1 forms a stretch-activated channel in SAN cells, our finding of SOCCs/TRPCs in these cells raises the possibility that TRPC1 may explain the effect of SAN stretch on heart rate. In this regard, TRPC1 has been suggested to function both as a stretch-sensitive channel and a SOCC in dystrophic skeletal muscle.47
In conclusion, we have demonstrated the utility of an intact murine SAN preparation that allows both structural and functional studies of the cardiac pacemaker. Our studies demonstrate SOCC activity in the mouse SAN and raise the possibility that TRPC isoforms are responsible for SOCC activity in SAN cells. This SOCC activity may contribute to the regulation of Ca2+ entry and pacemaker firing.
| Acknowledgments |
|---|
This work was supported by the National Health and Medical Research Council of Australia (Program grant 354400) and the Health Research Council of New Zealand.
Disclosures
None.
| Footnotes |
|---|
| References |
|---|
|
|
|---|
Related Article:
This article has been cited by other articles:
![]() |
M. E. Mangoni and J. Nargeot Genesis and Regulation of the Heart Automaticity Physiol Rev, July 1, 2008; 88(3): 919 - 982. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. L. Gervasio, N. P. Whitehead, E. W. Yeung, W. D. Phillips, and D. G. Allen TRPC1 binds to caveolin-3 and is regulated by Src kinase - role in Duchenne muscular dystrophy J. Cell Sci., July 1, 2008; 121(13): 2246 - 2255. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Alvarez, A. Coulombe, O. Cazorla, M. Ugur, J.-M. Rauzier, J. Magyar, E.-L. Mathieu, G. Boulay, R. Souto, P. Bideaux, et al. ATP/UTP activate cation-permeable channels with TRPC3/7 properties in rat cardiomyocytes Am J Physiol Heart Circ Physiol, July 1, 2008; 295(1): H21 - H28. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Younes, A. E. Lyashkov, D. Graham, A. Sheydina, M. V. Volkova, M. Mitsak, T. M. Vinogradova, Y. O. Lukyanenko, Y. Li, A. M. Ruknudin, et al. Ca2+-stimulated Basal Adenylyl Cyclase Activity Localization in Membrane Lipid Microdomains of Cardiac Sinoatrial Nodal Pacemaker Cells J. Biol. Chem., May 23, 2008; 283(21): 14461 - 14468. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |